other mammals, adult cardiac myocytes are thought to cardiac myocytes that result in focal sites of replacement have, at best, a very limited capacity for self-renewal [19] , fibrosis traditionally attributed to necrosis [27] . Recent and are intended to survive and actively function for the studies, however, have shown that experimentally-induced entire life of the organism. Viewed from this perspective, LV hypertrophy is associated with myocyte apoptosis [28-death of a significant number of adult cardiac muscle cells 30] . In rats with LV hypertrophy produced by aortic can have lasting adverse consequences on overall cardiac banding, Teiger et al. [28] identified myocyte apoptosis performance.
during the first 7 days after instituting aortic banding.
Studies from other laboratories suggested that cardiomyocyte apoptosis may be important in the transition 2. Cardiomyocyte apoptosis and predisposing factors from compensated hypertrophy to heart failure [29] . In for heart failure spontaneously hypertensive rats (SHR) with symptoms of heart failure, Li et al. [29] showed a near five-fold increase 2.1. Myocardial infarction in the number of cardiac myocytes undergoing apoptosis compared to nonfailing SHR rats. In this rat model, the Myocardial ischemia and infarction represent the major transition to heart failure was accompanied by features etiologies that underscore the development of congestive characteristic of the heart failure state including cardiac heart failure. Cardiomyocyte loss secondary to prolonged pump dysfunction [31] , myocardial fibrosis [32] , and ischemia has long been thought to result from overt reduction in the volume fraction of cardiac myocytes [33] . necrosis. While this form of cell death remains a primary
The incidence of apoptotic myocyte nuclei in failed SHR cause of tissue injury, recent studies have suggested that was |40 cells per 100 000 nuclei compared to |8 per cardiomyocyte loss after acute myocardial infarction can 100 000 nuclei in non-failed SHR rats. In age-matched also be caused by apoptosis [20] [21] [22] [23] [24] [25] . In studies in rats with WKY rats the incidence of apoptotic nuclei of myocyte myocardial infarction, internucleosomal DNA fragmentaorigin was |2 per cells per 100 000 nuclei [29] . These tion, evidenced by DNA laddering on agarose gel electroresults, while interesting, do not establish a cause and phoresis, was detected as early as 3 h after coronary artery effect relationship between apoptosis and transition to occlusion and was also present for up to 1 month after heart failure. coronary ligation primarily in regions adjacent to infarcted tissue and to a lesser extent in myocardial regions remote 2.3. Ventricular dilatation from the infarction [22] . Cardiomyocyte apoptosis has also been observed in humans following acute myocardial Left ventricular chamber enlargement is a characteristic infarction [23, 24] . In hearts obtained from patients with adaptation of the failing heart regardless of etiology. acute myocardial infarction who died within 10 days of the Chronic ventricular enlargement and failure can result onset of symptoms, Olivetti et al. [24] reported DNA from long-standing volume overload as in aortic or mitral strand breaks suggestive of apoptosis in 12% of myocytes valve insufficiency or the development of large conduit in the infarct border zone and in 1% of constituent vessel arterio-venous fistulas. As with ventricular hypermyocytes of myocardial regions remote from the infarctrophy, LV chamber dilation is associated with loss of tion. In a study by Saraste et al. [23] , hearts from patients cardiac myocytes that result in focal sites of fibrosis. who died of an acute myocardial infarction and had patent Recent studies have shown that passive myocardial stretch infarct-related arteries at autopsy, also showed extensive is also associated with cardiomyocyte apoptosis [34] . In DNA strand breaks in cardiomyocytes. In this same study, vitro studies by Cheng et al. [34] showed a 21-fold higher apoptotic cardiomyocytes were observed primarily in incidence of myocyte DNA strand breaks in rat posterior myocardial regions that bordered the infarction [24] . As papillary muscles exposed to high tension levels as a result will be discussed in subsequent parts of this review, the of overstretch compared to papillary muscles exposed to observation of a high prevalence of cardiomyocyte apoplower tension levels. DNA laddering studies using extracts tosis in the peri-infarct border region in comparison to from muscles exposed to high stretch also revealed the myocardial regions remote from the infarction is also presence of DNA fragments consistent with apoptosis evident in myocardium of both humans with chronic heart while degradation of DNA was not observed in nonfailure secondary to ischemic cardiomyopathy as well as in overstretched papillary muscles [34] . These data suggest animal models of chronic heart failure produced by that myocardial stretch alone, as can occur under conintracoronary microembolizations [12, 26] .
ditions of acute or chronic volume overload, may be associated with cardiomyocyte loss through apoptosis. 2.2. Ventricular hypertrophy 2.4. Autoimmunity Heart failure can result from sustained pressure overload as in long-standing hypertension or aortic valvular
In inflammatory heart muscle disease, autoimmunity is stenosis. Ventricular hypertrophy is associated with loss of considered to play a role in the pathogenesis of impaired cardiac performance [35] . Marked depression of cardiac from ongoing loss of viable cardiomyocytes is no longer function occurs in patients with dilated cardiomyopathy in relegated to the realm of pure speculation. Studies in the absence of extensive loss of viable myocardium. In a myocardium of animal models of experimentally-induced subset of this population, the etiology and pathogenesis heart failure as well as studies in end-stage explanted points to an inflammatory origin as in myocarditis. Under failed human hearts have provided strong evidence for the such circumstances, the immune response to the invading existence of cardiac myocyte apoptosis. The very fact that pathogen is the major determinant of the severity, course myocyte apoptosis occurs in chronic heart failure, albeit at and progression of the disease. Secretory products of a pace yet to be defined and with a magnitude yet immune cells such as macrophages and other infiltrating uncertain, supports the concept of ongoing loss of funccells could well contribute to abnormalities of contraction tional cardiac units. Cardiomyocyte apoptosis was idenand relaxation that are seen, for instance, in myocarditis tified in dogs with heart failure produced by multiple [35] . Proinflammatory cytokines such as tissue necrosis sequential intracoronary microembolization [12] ; a model factor-a (TNF-a), interleukin (IL)-1, IL-2 and IL-6 are that manifests many of the classic sequelae of heart failure antigen-nonspecific glycoproteins that are synthesized seen in humans, including marked and sustained depresrapidly and released locally by immune cells in response to sion of LV systolic function, LV hypertrophy and dilation injury [36] . Cytokines have been shown to reduce the and enhanced activity of the sympathetic nervous system positive inotropic response of isolated cardiac myocytes to [43] . In dogs with heart failure, the existence of caradrenergic agonists [37] . TNF-a and IL-1 have also been diomyocyte apoptosis was established by uncovering ultrashown to uncouple agonist-occupied receptors from structural features of this form of cell death as well as by adenylate cyclase in isolated cardiac myocytes [37] . Of immunohistochemical staining for nuclear DNA strand particular importance to the present discussion is the breaks using the TUNEL assay. Electron microscopic potential role for proinflammatory cytokines, and in parevidence of cardiomyocytes at various stages of apoptosis ticular TNF-a, in the induction of cardiomyocyte apoptosis were identified in LV tissue obtained from dogs with heart [38] . TNF-a is overexpressed in patients with heart failure failure but not in LV tissue obtained from normal dogs regardless of etiology [39] . Plasma levels of TNF-a were [12] . Features of early stages of apoptosis included comshown to be elevated in patients with NYHA class I-III paction of nuclear chromatin into dense masses that abut heart failure compared with age-matched controls and were on the nuclear envelop. In these cells, the inner organelles progressively elevated in relation to decreasing functional were preserved and the sarcolemma was intact. Features of status [40] . Transgenic mice with cardiac-specific overcardiomyocytes in advanced stages of apoptosis included expression of TNF-a have been shown to manifest an intact sarcolemma in the presence of highly disorganlymphohistocytic myocarditis, cardiomegaly and congesized inner organelles with only remnants of myofibrils and tive heart failure [41] . In this transgenic mouse, over-Z-band material that allows the recognition of these bodies expression of TNF-a was associated with increased incias cardiomyocytes in origin. Myocytes in advanced stages dence of cardiomyocyte apoptosis shown by both DNA of apoptosis also manifested sarcolemmal blebbing or laddering and terminal deoxynucleotidyl transferase-mesevere endocytosis along with cell shrinkage [12, 44] . diated deoxyuridine triphosphate nick-end labeling Apoptotic cardiomyocytes were primarily localized to LV (TUNEL) assay. The increased incidence of myocyte regions bordering old infarcts, were frequently encircled apoptosis in this model was also associated with activation by large amounts collagen and had an intact sarcolemma of multiple members of the apoptosis pathway that inwith absence of associated inflammation, the latter being a cluded Fas and Bax [42] . The fact that TNF-a is a potent key distinguishing feature of apoptosis compared to necroinducer of apoptosis is not surprising. Cardiomyocytes sis [12] . In the same dog model, the number of carexpress functional TNF type-1 receptors and have been diomyocytes undergoing apoptosis was quantified hisshown to undergo apoptosis after stimulation with TNF-a tomorphometrically based on an assessment of the number in vitro [38] . Clinical trials are currently underway to of myocytes positively labeled for nuclear DNA strand determine whether chronic inhibition of TNF-a is benefibreaks per 1000 cardiomyocytes [11] . Assessments were cial in the treatment of patients with heart failure. made in LV regions bordering old infarcts or scar tissue as well as in LV regions remote from any infarcts. As in previous studies [12] , the number of cardiomyocytes undergoing apoptosis was significantly higher in LV 3. Evidence for cardiomyocyte apoptosis in animal regions bordering old infarcts compared to LV regions models of heart failure remote from any infarcts (4.060.5 vs. 0.560.3 nuclear DNA fragmentation events per 1000 cardiomyocytes). This Even though the exact mechanisms that underly the observation further suggests that in the failing heart, the process of progressive LV dysfunction in heart failure is peri-infarct border region may be a primary site of not known, the possibility that this process results, in part, myocyte loss through apoptosis, a finding consistent with the observation of profound ultrastructural abnormalities of are susceptible to hypoxia, a physiologic condition cardiomyocyte in these regions [12, 45] . Cardiomyocyte believed to promote apoptosis. apoptosis was also examined in dogs with heart failure produced by rapid ventricular pacing [46] . DNA laddering, with stretches of DNA equivalent to 160 bp and 320 bp 4. Evidence for cardiomyocyte apoptosis in humans being most abundant, was detected in myocardium of dogs with heart failure with heart failure but not in sham-operated control dogs [46] . Consistent with this finding an average of 3700
Studies in tissues obtained from explanted hearts of myocyte nuclei per million was detected as undergoing patients with end-stage heart failure have confirmed the apoptosis based on positive dUTP-labeling. Also consistent presence of cardiomyocyte apoptosis [13, 14, 26, 50] . Narula with observations in the microembolization model of heart et al. [13] examined tissue from seven explanted failed failure, groups of apoptotic myocytes were frequently human hearts for evidence of cardiomyocyte apoptosis. found in proximity of small areas of replacement fibrosis Four of seven patients in whom heart failure was due to [46] . idiopathic dilated cardiomyopathy (IDC) had immunoAge is an independent risk factor for the development of histochemical evidence of cardiomyocyte nuclear DNA congestive heart failure. Interestingly, the aging process in fragmentation by TUNEL technique and demonstrated humans and in animals is also associated with a significant DNA laddering consistent with apoptosis. In three of seven loss of cardiac myocytes [47] [48] [49] . It is estimated that the patients with ischemic cardiomyopathy (ICM) [13] one aging process may itself contribute to loss of nearly 30% patient had evidence of cardiomyocyte nuclear DNA of all of LV myocytes [48, 49] . This ongoing cell loss may fragmentation by TUNEL technique and none were posibe partly responsible for the increased risk of development tive for apoptosis based on DNA laddering. This small and of ventricular dysfunction and failure in the elderly.
largely inconclusive study, was followed by a much larger Several studies have evoked apoptosis as a contributory and more convincing study by Olivetti et al. [14] . In tissue process to the overall loss of cardiomyocyte in the aging samples from eight normal donor hearts, Olivetti and heart [29, 49] . Kajstura et al. [49] used Fischer 344 rats of colleagues reported TUNEL positive cardiomyocyte nuclei varying age from 3 to 24 months to quantify carin only 10 nuclei / million. In 15 failed hearts, this value diomyocyte necrosis and apoptosis. Results showed that in increased from a minimum of 673 to a maximum of 6549 the LV free wall, the extent of both myocyte necrosis and nuclei / million. There was no difference in the number of apoptosis increased with increasing age. Cell necrosis, apoptotic myocyte nuclei in patients with IDC (2366 based on in vivo labeling with antimyosin antibody nuclei / million, n55) compared to patients with heart occurred in less than two myocytes / 1000 at 3 months of failure due to ICM (2436 nuclei / million, n59) [14] . In age and increased to nearly 13 myocytes / 1000 at 12 contrast to the results of the study by Narula et al. [13] , months of age. Cardiomyocyte apoptosis was evident in they showed DNA laddering in myocardium of patients nearly 10 myocytes / million at age 3 and increased to over with IDC and ICM [14] . In a more recent study, a higher 80 myocytes / million at 24 months of age. In this rat incidence of cardiomyocyte apoptosis was reported in model, the progressive increase in apoptotic and necrotic failed hearts of patients with ICM compared to patients cell death was associated with the development of venwith IDC (0.31 vs. 0.10 apoptotic myocytes / 1000) [26] . tricular dysfunction and failure which became clinically The higher number of apoptotic myocytes in ICM was due apparent between 16 and 24 months of age [49] . An largely to a near three-fold higher incidence of apoptosis in interesting finding of this study was the observation that, in regions bordering old infarcts compared to myocardial contrast to cell necrosis, which tended to peak early and regions remote from any infarcts (0.50 vs. 0.06 apoptotic level off between 12 and 24 months of life, apoptosis myocytes / 1000) [26] . In patients with acromegaly induced tended to increase sharply between 12 and 24 months of cardiomyopathy, Frustaci et al.
[51] reported a near 500-life suggesting, perhaps, that triggers of both forms of cell fold increase in apoptosis of cardiomyocytes compared to death may be different. This temporal difference between that observed in myocardial tissue samples obtained from necrosis and apoptosis can also be explained on the basis papillary muscle of patients undergoing mitral valve of formation of islets of scar tissue. It is quite likely that replacement. Biochemically, apoptosis is characterized by 21 21 cell necrosis, which preceded apoptosis, may have led to internucleosomal cleavage of DNA by Ca and Mgdiscrete sites of replacement fibrosis and trigger apoptosis dependent endonuclease whose activity increases during in viable myocardial regions that border the fibrous scar as apoptosis [52] . Yao et al. [50] showed that deoxyribonuseen in dog models of heart failure described earlier as clease I (DNase I), which is indistinguishable from endowell as in explanted failed human hearts [12, 26, 46] . The nuclease [53] , is significantly increased in myocardium of exact mechanism or mechanisms responsible for apoptosis patients with end-stage heart failure compared to myocarin peri-infarct regions remain uncertain. One possible dium of non-diseased hearts. The above studies in human explanation is that myocardial regions that border infarcts hearts, when considered in aggregate, strongly suggest that apoptosis of cardiomyocytes occurs in heart failure regardless of the predisposing factor.
Molecular triggers of apoptosis in heart failure
The multigene family of Bcl-2-like proteins, some of which such as Bcl-2 itself inhibits apoptosis and others such as Bax which promote apoptosis is one of the best known regulators of the apoptotic process [54] [55] [56] . The ratio of Bcl-2 to Bax, the so-called 'death switch' is often used as an indicator of apoptosis. An increase in this ratio is used to signify attenuation of the apoptotic process whereas a decrease in the ratio is used to signify exacerbation of the apoptotic process. In viable myocardium of rats and an increase in the expression of Bax, an imbalance that 9 which can cleave and activate caspase. 3 AIP can also activate favors apoptosis. In myocardium of SHR with heart caspase-3 leading to formation of various death substrates that produce failure, expression of Bcl-2 was unchanged compared to apoptosis. Bcl-2 can interfere with cytochrome c release and can also non-failing SHR rats [29] . In explanted failed human suppress the actions of Apaf-1 and, in turn, protect from apoptosis.
hearts, Olivetti et al. [14] reported a near doubling of the expression of Bcl-2 in cardiac tissue without changes in the expression of Bax, a situation that favors protection from apoptosis. Another factor involved in apoptosis is the appears to prevent activation of the ICE protease cascade tumor suppressor p53 protein implicated in cell cycle arrest [64] , possibly by preventing release of cytochrome c. through upregulation of p21 / WAF-1, a cyclin-dependent Mitochondrial abnormalities have been described in pakinase (Cdk) inhibitor [56] . The p53 protein is believed to tients and in dogs with heart failure that include structural induce apoptosis in response to DNA damage [57] and disruption of the inner membrane, hyperplasia, and reother signals such as increased expression of c-myc in a duced organelle size [7] . In myocardium of dogs with manner independent of cell cycle arrest [58] . In myocarchronic heart failure we have also shown a marked dium of SHR rats with heart failure, Li et al. [29] showed a decrease in mitochondrial respiratory parameters compared significant increase WAF-1 mRNA levels in comparison to to normal dogs [65] . While requiring further confirmatory levels in myocardium of non-failing rats. studies, the role of mitochondria in mediating myocyte A family of cysteine proteases known as interleukinapoptosis in the failing heart could be central indeed given converting enzymes (ICE) more recently referred to as its crucial in apoptosis of other cell types. A cell surface 'caspases' have recently taken a front and center seat as antigen Fas, a member of the TNF family, is also involved primary regulators of apoptosis. Studies in rats with acute in the regulation of apoptosis by acting as a receptor for myocardial infarction [59, 60] , have suggested that ICE-like the ligand FasL which induces apoptosis; a sequence that proteases modulate apoptosis based on the ability of has become known as the 'death domain'. Recent studies certain pharmacologic inhibitors, such as z-VAD-fmk, a have shown that circulating levels of soluble Fas, a non-specific peptide caspase inhibitor, to block the apopmolecule that lacks the transmembrane domain of Fas and, tosis process. In a recent study, the expression of caspase-3 therefore, inhibits apoptosis, is increased in patients with was examined in LV tissue obtained from failing human congestive heart failure [66, 67] . In contrast to these hearts [61] . In this study, caspase-3 was strongly induced studies, other studies have reported increased circulating in myocytes bordering recent infarcts and to a lesser extent levels of soluble Fas ligand (FasL) in patients with in failing hearts due to dilated cardiomyopathy. Co-localicongestive heart failure [68] . Soluble FasL is a molecule zation of caspase-3 with apoptotic cardiomyocytes has that promotes binding between Fas and FasL and favors been reported in rats following myocardial ischemia and apoptosis. reperfusion [60] . The release of cytochrome c or the Abnormal cell cycle events, cell cycle progression in the release of 'apoptosis inducing factor' from mitochondria face of DNA damage and forcing cell cycle reentry in may be an important pathway for the activation of caspases terminally differentiated cells are all potent inducers of with resulting apoptosis in the failing heart [62] (Fig. 1) .
apoptosis [69] [70] [71] [72] . Cardiac hypertrophy and failure are Cytochrome c release from mitochondria has been shown associated with DNA synthesis in myocytes and with to precede caspase activation in apoptotic cardiomyocytes upregulation of molecular markers of cell cycle progresduring ischemia in the rat [63] . Expression of Bcl-2 sion [42, 73] . An increase in proliferating cell nuclear antigen (PCNA), a nuclear protein necessary for DNA synthesis and cell cycle progression [74] was reported in myocardium of dogs with heart failure induced by rapid ventricular pacing [46] . Coordination of events that occur during the cell cycle is also dependent on a series of cyclin-dependent kinases (Cdks) that, as active complexes, appear to be important for the progression from G to 2 mitosis [75] . Progression through G also requires in-1 activation of several tumor suppressor genes including p53, p21, p16, p15 and p27 and the retinoblastoma gene Rb, that inhibit the kinase activity of the cyclin / Cdk complexes [75] . In a recent study, Burton et al. [76] of patients with end-stage heart failure compared to normal NE, norepinephrine; TNFa, tissue necrosis factor a.
donor hearts, a finding consistent with initiation of cell cycle activation. Studies by Anversa and Kajstura [77] suggested that adult cardiac myocytes are able to divide and that this capacity increases during cardiac disease including heart failure. However, the overall frequency of the sympathetic nervous system as well as localized or such cell division, if true, remains very low, and its even global hypoxia, are in many respects characteristic significance in modulating the disease state is, at the features of the failing heart and have long been implicated present time, uncertain. Another possibility is that carin the progression of the disease. Exposure of isolated diomyocytes stimulated to divide are driven toward apopadult rat cardiomyocytes to A-II was shown to cause a near tosis. Evidence for this can be found in studies in which five-fold increase in apoptosis [94] . When cardiomyocyte DNA synthesis induced in cardiomyocytes transfected with were exposed to A-II in the presence of losartan, a E1A gene, resulted in apoptosis rather cell division [78] .
selective AT -receptor antagonist, apoptosis was complete- 1 The above discussion only briefly describes those signal ly blocked [94] . Consistent with this finding, we observed transduction pathways that are potentially relevant to an attenuation of cardiomyocyte apoptosis in dogs with cardiomyocyte apoptosis in the failing heart. A more microembolization-induced heart failure treated long-term detailed treatment of the apoptotic signaling pathways can with the angiotensin-converting enzyme (ACE) inhibitor be found in many comprehensive reviews on the subject enalapril [96] . ACE inhibition has also been shown to [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] .
attenuate apoptosis in rats with heart failure [29] . Exposure of isolated adult rat cardiomyocyte to norepinephrine caused a near two-fold increase in apoptosis [95] . When myocytes were exposed to norepinephrine in the presence 6. Pathophysiological triggers of apoptosis in heart of the mixed b -and b -adrenergic antagonist propranolol, 1 2 failure the effect was completely blocked [95] . Consistent with these findings in isolated rat myocytes, we observed a There is ample evidence to suggest that pathophysiologimarked reduction of cardiomyocyte apoptosis in dogs cal conditions, common to the heart failure state, are treated long-term with the b -selective blocker metoprolol 1 important regulators of cardiac myocyte apoptosis (Fig. 2) .
[97]. The attenuation of myocyte apoptosis with metoIt is often suggested that apoptosis may be induced by the prolol was associated with an increase in the Bcl-2 to Bax same agents that produce necrosis with the type of cell ratio, a finding that favors cell survival. Several studies death being dependent on the severity of the insult rather provide support for the role of hypoxia as a potential than its qualitative nature [89] . The observation that inducer of cardiomyocyte apoptosis. Exposure of cultured increased cytosolic calcium concentration can lead to rat neonatal cardiac myocytes to hypoxia was shown to apoptosis [90] is consistent with this concept. Other factors induce apoptosis as evidenced by positive labeling for implicated as triggers of cardiomyocyte apoptosis include nuclear DNA fragmentation [92] . In the same study, the formation of oxygen free radicals [91] , exposure to enhanced expression of Fas antigen was also noted in hypoxia [92, 93] , excess levels of angiotensin-II (A-II) response to hypoxia. ICE-like proteases have also been [94] , excess levels of norepinephrine [95] and increased shown to be involved in the hypoxia-induced apoptosis in levels of specific cytokines such as TNFa [38, 39] . Among cardiac myocytes [98] . Hypoxic stress has also been these, the role of A-II, norepinephrine and limited oxygensuggested to increase the expression and nuclear accumulaation of the myocardium have received considerable tion of specific proto-oncogenes such as c-fos, c-jun and attention in recent years and for good reason. Enhanced c-myc that also have been implicated in the induction of and sustained activity of the renin-angiotensin system and cell cycle progression and apoptosis [99] [100] [101] .
progression of left ventricular dysfunction in patients with heart 7. Importance of cardiomyocyte apoptosis in the concept that cardiomyocyte apoptosis occurs in heart contractile structures in viable myocytes of the failing heart. Int J
